Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning-Reference-Cited by-同舟云学术

Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning

Published:2017-09 Issue: Volume:53 Page:15-23
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Cuypers Lize,Libin Pieter,Schrooten Yoeri,Theys Kristof,Di Maio Velia Chiara,Cento Valeria,Lunar Maja M.,Nevens Frederik,Poljak Mario,Ceccherini-Silberstein Francesca,Nowé Ann,Van Laethem Kristel,Vandamme Anne-Mieke

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference70 articles.

1. A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences;Alcantara;Nucleic Acids Res.,2009

2. ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection;Andreone;Gastroenterology,2014

3. Boceprevir for previously treated chronic HCV genotype 1 infection;Bacon;N. Engl. J. Med.,2011

4. Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies;Barnard;Virology,2013

5. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naïve subjects;Bartels;J. Infect. Dis.,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research;Briefings in Bioinformatics;2020-11-04

2. Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1—Overview of Knowledge Discovery Techniques in Artificial Intelligence;Frontiers in Pharmacology;2020-07-16

3. 1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease;Biomolecules;2020-03-21

4. A novel molecular mechanism to explain mutations of the HCV protease associated with resistance against covalently bound inhibitors;Virus Research;2019-12

5. Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran;Infection, Genetics and Evolution;2019-11